Table 2.
Aggregation of metabolic factors and breast cancer.
| Diagnostic criteria | Aggregation of metabolic factors | All subjects | |||
|---|---|---|---|---|---|
| Case | Control | OR | 95% CI | ||
| IDF 2005 | 0 | 312 (52.4%) | 325 (61.1%) | 1.000 | |
| 1–2 | 131 (22.0%) | 90 (16.9%) | 1.516 | 1.112–2.067 | |
| 3 | 94 (15.8%) | 64 (12.0%) | 1.530 | 1.074–2.179 | |
| 4 | 32 (5.4%) | 39 (7.3%) | 0.855 | 0.522–1.399 | |
| 5 | 26 (4.4%) | 14 (2.6%) | 1.935 | 0.992–3.773 | |
| Ptrend | 0.039 | ||||
| ATPIII 2005 | 0 | 109 (18.3%) | 99 (18.6%) | 1.000 | |
| 1–2 | 331 (55.6%) | 284 (53.4%) | 1.059 | 0.773–1.450 | |
| 3 | 95 (16.0%) | 102 (19.2%) | 0.846 | 0.573–1.249 | |
| 4 | 41 (6.9%) | 36 (6.8%) | 1.034 | 0.613–1.747 | |
| 5 | 19 (3.2%) | 11 (2.1%) | 1.569 | 0.711–3.460 | |
| Ptrend | 0.514 | ||||
| CDS 2007 | 0 | 202 (33.9%) | 169 (31.8%) | 1.000 | |
| 1–2 | 321 (53.9%) | 309 (58.1%) | 0.869 | 0.672–1.124 | |
| 3 | 54 (9.1%) | 43 (8.1%) | 1.051 | 0.670–1.647 | |
| 4 | 13 (2.2%) | 9 (1.7%) | 1.208 | 0.504–2.896 | |
| 5 | 5 (0.8%) | 2 (0.4%) | 2.092 | 0.401–10.918 | |
| Ptrend | 0.781 | ||||
| Joint statement 2009 | 0 | 109 (18.3%) | 99 (18.6%) | 1.000 | |
| 1–2 | 331 (55.6%) | 284 (53.4%) | 1.059 | 0.773–1.450 | |
| 3 | 95 (16.0%) | 102 (19.2%) | 0.846 | 0.573–1.249 | |
| 4 | 41 (6.9%) | 36 (6.8%) | 1.034 | 0.613–1.747 | |
| 5 | 19 (3.2%) | 11 (2.1%) | 1.569 | 0.711–3.460 | |
| Ptrend | 0.514 | ||||